Annotated Medicine and Device Lists
| List | Section | Observation |
|---|---|---|
| Brasil. Relação Nacional de Medicamentos Essenciais. 2020 | A. APARELHO DIGESTIVO E METABOLISMO | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines 2019 | 18.5.2 Oral hypoglycaemic agents |
This medicine has the best evidence for effectiveness and safety. |
| Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. | Endocrine Oral Hypoglycemic | No observations |
| Costa Rica. Caja Costarricense de Seguro Social. 2019 | 39. Hipoglucemiantes e hiperglucemiantes | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines 2019 | 18.5.2 Oral hypoglycaemic agents |
This medicine has the best evidence for effectiveness and safety. |
| Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. | Endocrine Oral Hypoglycemic | No observations |
| Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 | 05.01 DRUGS USED IN DIABETES | No observations |
| List | Section | Observation |
|---|---|---|
| WHO Model List of Essential Medicines 2019 | 18.5.2 Oral hypoglycaemic agents |
This medicine has the best evidence for effectiveness and safety. |
| Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 | 05.01 DRUGS USED IN DIABETES | No observations |
| List | Section | Observation |
|---|---|---|
| Brasil. Relação Nacional de Medicamentos Essenciais. 2020 | A. APARELHO DIGESTIVO E METABOLISMO | No observations |
| List | Section | Observation |
|---|---|---|
| Brasil. Relação Nacional de Medicamentos Essenciais. 2020 | A. APARELHO DIGESTIVO E METABOLISMO | No observations |